Poly Medicure (531768) Q4 01/02 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 01/02 earnings summary
2 Nov, 2026Executive summary
FY 2001-02 sales reached Rs. 304.92 million versus Rs. 177.82 million; profit after tax was Rs. 28.55 million versus Rs. 17.86 million.
Higher production drove results; the expansion project was commissioned, with full benefits expected in FY 2002-03.
Financial highlights
Total income was Rs. 307.93 million versus Rs. 180.13 million; operating profit was Rs. 64.28 million versus Rs. 40.89 million.
Profit before tax was Rs. 36.73 million versus Rs. 19.04 million; profit after tax was Rs. 28.55 million versus Rs. 17.86 million.
Current tax was Rs. 1.90 million and deferred tax expense Rs. 6.28 million; basic EPS was Rs. 6.15 versus Rs. 3.91.
Export earnings were Rs. 165.10 million versus Rs. 85.20 million; foreign-exchange outgo was Rs. 78.90 million versus Rs. 51.60 million.
Outlook and guidance
FY 2002-03 expected to benefit from stabilization of newly installed capacity; management anticipated higher turnover and surplus despite competition.
Further expansion plans were in progress after commissioning the prior expansion project.
Latest events from Poly Medicure
- Acquisition-led revenue growth and a European rebound faced pressure on consolidated margins.531768
Q2 26/27 - Commercial production began in Apr 1997 after delays; FY turnover and PBT were nil.531768
Q4 96/97 - Revenue and production grew, but depreciation drove a FY99 net loss.531768
Q4 98/99 - First-period profit was modest as depressed markets and blood-bag restrictions curtailed performance.531768
Q4 97/98 - Profit returned as production grew 77.10% and export turnover nearly doubled.531768
Q4 99/00 - FY04 growth and capacity expansion advanced, with exports at 83.8% of sales.531768
Q4 03/04 - Profit and exports surged as capacity expansion and Egypt production plans advanced.531768
Q4 02/03 - Record production and higher profit fuel expansion amid pricing and currency pressures.531768
Q4 05/06 - Sales rose 31.2%, PAT climbed 40.4%, and exports reached 86.4% of sales.531768
Q4 04/05